Search

everythinglearnresearchcommunity

for

Search:↓

A woman's severe hirsutism was caused by Leydig cell tumors in her ovaries, which improved after surgery.

The modified Ferriman-Gallwey method is a useful tool for diagnosing hirsutism.

Hair loss may indicate higher risk of heart disease.

Women with PCOS risk had normal height and blood tests but higher weight and common acne or hirsutism.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

The conclusion is that a safe donor area for hair transplants varies and should be chosen based on individual factors like race, future hair loss, family history, and specific thinning patterns.

Women have smaller foreheads and different hairline shapes than men.

The document concludes that HAIR-AN syndrome should be considered when a patient shows severe hyperandrogenism and insulin resistance after excluding tumors.

Glypican-4 may help indicate insulin sensitivity and lipid issues in women with PCOS.

A woman's hyperandrogenism was caused by a genetic mutation leading to non-classic adrenogenital syndrome.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

The document suggests new ways to assess and diagnose hyperandrogenism to improve accuracy.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

Acanthosis nigricans is common in obese individuals, but not significantly linked to obesity type.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

Alopecia in transgender individuals on hormone therapy can worsen emotional distress and affect self-esteem.

Digital imaging can effectively evaluate the donor area for hair transplants, showing variations in hair density and grouping by age and severity of hair loss.

Hair density and thickness decrease in specific scalp areas in people with androgenetic alopecia.

Finasteride caused enlarged breast tissue in a 62-year-old man.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

LH and hCG reduce certain protein levels in women's skin.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

A man's breast enlargement from low-dose finasteride for hair loss didn't go away, even with treatment, and might be more common than reported.

Higher anxiety levels are linked to sexual dysfunction in women with PCOS.

People with androgenetic alopecia have a higher risk of metabolic syndrome.

Hirsutism and acanthosis nigricans are reliable skin signs of PCOS and suggest the need for further tests for related health issues.

Some men with early hair loss may have a male version of PCOS, affecting hormones and increasing health risks.

Women with hair loss have higher heart disease risk and unhealthy cholesterol levels.

Women with excessive body hair often have higher male hormones and related health issues.

Androgens affect many aspects of female health, and more research is needed to understand their roles and treatment potential.